Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 11/20 | 0.60 |
| ▸ | F10 | P00742 | 11/20 | 0.60 |
| ▸ | PLAU | P00749 | 9/20 | 0.60 |
| ▸ | PLAT | P00750 | 7/20 | 0.60 |
| ▸ | PLG | P00747 | 7/20 | 0.58 |
| ▸ | F7 | P08709 | 5/20 | 0.58 |
| ▸ | F3 | P13726 | 5/20 | 0.58 |
| ▸ | KLK1 | P06870 | 2/20 | 0.47 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.42 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7663237 | 0.90 | F2 (0.60) | F2F10PLAUPLATPLG | |
| SCHEMBL7657479 | 0.89 | F2 (0.55) | F2F10PLAUPLATPLG | |
| SCHEMBL7660871 | 0.89 | F2 (0.58) | F2F10PLAUPLATPLG | |
| SCHEMBL7653542 | 0.89 | F2 (0.53) | F2F10PLAUPLATPLG | |
| SCHEMBL7653276 | 0.87 | F2 (0.57) | F2F10PLAUPLATPLG | |
| SCHEMBL7657164 | 0.87 | F2 (0.71) | F2F10PLAUPLATPLG | |
| SCHEMBL7686535 | 0.87 | F2 (0.71) | F2F10PLAUPLATPLG | |
| SCHEMBL7656807 | 0.86 | F2 (0.53) | F2F10PLAUPLATPLG | |
| SCHEMBL7666093 | 0.85 | F2 (0.60) | F2F10PLAUPLATPLG | |
| SCHEMBL7655482 | 0.85 | F2 (0.60) | F2F10PLAUPLATPLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6358960-B1 | FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-03-19 | — | — | US | disclosed |
| EP-1078917-A1 | AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-02-28 | — | — | EP | disclosed |